SE0104295D0 - New process - Google Patents
New processInfo
- Publication number
- SE0104295D0 SE0104295D0 SE0104295A SE0104295A SE0104295D0 SE 0104295 D0 SE0104295 D0 SE 0104295D0 SE 0104295 A SE0104295 A SE 0104295A SE 0104295 A SE0104295 A SE 0104295A SE 0104295 D0 SE0104295 D0 SE 0104295D0
- Authority
- SE
- Sweden
- Prior art keywords
- preparation
- relates
- new process
- rabeprazole
- pantoprazole
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- -1 2-pyridinyl Chemical group 0.000 abstract 1
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 abstract 1
- IQPSEEYGBUAQFF-UHFFFAOYSA-N Pantoprazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC=C(OC(F)F)C=C3N=2)=C1OC IQPSEEYGBUAQFF-UHFFFAOYSA-N 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 229960003174 lansoprazole Drugs 0.000 abstract 1
- MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960000381 omeprazole Drugs 0.000 abstract 1
- 229960005019 pantoprazole Drugs 0.000 abstract 1
- 229960004157 rabeprazole Drugs 0.000 abstract 1
- YREYEVIYCVEVJK-UHFFFAOYSA-N rabeprazole Chemical compound COCCCOC1=CC=NC(CS(=O)C=2NC3=CC=CC=C3N=2)=C1C YREYEVIYCVEVJK-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0104295A SE0104295D0 (sv) | 2001-12-18 | 2001-12-18 | New process |
CA002468688A CA2468688A1 (en) | 2001-12-18 | 2002-12-17 | New process |
JP2003552751A JP2005517656A (ja) | 2001-12-18 | 2002-12-17 | 新規な方法 |
EP02793664A EP1458709A1 (en) | 2001-12-18 | 2002-12-17 | New process |
PCT/SE2002/002356 WO2003051867A1 (en) | 2001-12-18 | 2002-12-17 | New process |
AU2002359151A AU2002359151A1 (en) | 2001-12-18 | 2002-12-17 | New process |
US10/498,944 US20050049282A1 (en) | 2001-12-18 | 2002-12-17 | Process |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0104295A SE0104295D0 (sv) | 2001-12-18 | 2001-12-18 | New process |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0104295D0 true SE0104295D0 (sv) | 2001-12-18 |
Family
ID=20286395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0104295A SE0104295D0 (sv) | 2001-12-18 | 2001-12-18 | New process |
Country Status (7)
Country | Link |
---|---|
US (1) | US20050049282A1 (sv) |
EP (1) | EP1458709A1 (sv) |
JP (1) | JP2005517656A (sv) |
AU (1) | AU2002359151A1 (sv) |
CA (1) | CA2468688A1 (sv) |
SE (1) | SE0104295D0 (sv) |
WO (1) | WO2003051867A1 (sv) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100348595C (zh) * | 2005-03-17 | 2007-11-14 | 浙江大学宁波理工学院 | 奥美拉唑对映体的模拟移动床色谱分离方法 |
EP1801110A1 (en) | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Esomeprazole arginine salt |
US7553857B2 (en) | 2005-12-23 | 2009-06-30 | Lek Pharmaceuticals D.D. | S-omeprazole magnesium |
US8404853B2 (en) | 2006-07-05 | 2013-03-26 | Lupin Limited | Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds |
EP1947099A1 (en) | 2007-01-18 | 2008-07-23 | LEK Pharmaceuticals D.D. | Process for solvent removal from omeprazole salts |
EA200900985A1 (ru) | 2007-01-31 | 2009-12-30 | Крка, Товарна Здравил, Д. Д., Ново Место | Способ получения оптически чистого омепразола |
FR2920428B1 (fr) * | 2007-08-29 | 2012-06-15 | Univ Rouen | Procede de dedoublement de sels de l'omeprazole |
EP2143722A1 (en) | 2008-07-09 | 2010-01-13 | Lek Pharmaceuticals D.D. | Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
CN102143789B (zh) * | 2008-08-26 | 2013-12-25 | 大赛璐化学工业株式会社 | 使用模拟移动床色谱分离装置制造目标物质的方法 |
US20100113527A1 (en) * | 2008-09-30 | 2010-05-06 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of dexlansoprazole |
KR101001646B1 (ko) * | 2008-12-12 | 2010-12-17 | 한미약품 주식회사 | (r)-(+)-란소프라졸의 제조방법 및 이에 사용되는 중간체 |
EP2522647B1 (en) | 2011-05-10 | 2014-04-30 | DSM IP Assets B.V. | Process of separating chiral isomers of chroman compounds and their derivatives and precursors |
EP2573063A1 (en) | 2011-09-23 | 2013-03-27 | DSM IP Assets B.V. | Process for preparing chiral quinone |
CN103193572B (zh) * | 2013-04-07 | 2015-06-17 | 山东大学 | 一种拉唑类化合物单一对映体的分离方法 |
US20180155311A1 (en) | 2015-05-26 | 2018-06-07 | Dsm Ip Assets B.V. | Separation of chiral isomers by sfc |
CN106928190A (zh) * | 2015-12-29 | 2017-07-07 | 中美华世通生物医药科技(武汉)有限公司 | 利用模拟移动床色谱分离制备兰索拉唑的方法 |
CN106390519A (zh) * | 2016-09-12 | 2017-02-15 | 华东理工大学 | 多柱模拟移动床色谱技术连续分离氨鲁米特外消旋体的方法 |
JP7335002B2 (ja) * | 2019-08-29 | 2023-08-29 | 学校法人東京理科大学 | スルホキシド化合物のエナンチオマー調製方法及びエナンチオマー調製システム |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2985589A (en) * | 1957-05-22 | 1961-05-23 | Universal Oil Prod Co | Continuous sorption process employing fixed bed of sorbent and moving inlets and outlets |
US2957927A (en) * | 1957-06-27 | 1960-10-25 | Universal Oil Prod Co | Process for separating normal aliphatic hydrocarbons from hydrocarbon mixtures |
NL293774A (sv) * | 1962-06-08 | |||
US3291726A (en) * | 1964-05-04 | 1966-12-13 | Universal Oil Prod Co | Continuous simulated countercurrent sorption process employing desorbent made in said process |
US3310486A (en) * | 1964-08-13 | 1967-03-21 | Universal Oil Prod Co | Separation process for the recovery of high purity components of hydrocarbon mixtures |
IL75400A (en) * | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
JPS6150978A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
FI90544C (sv) * | 1986-11-13 | 1994-02-25 | Eisai Co Ltd | Förfarande för framställning såsom läkemedel användbara 2-pyridin-2-yl-metyltio- och sulfinyl-1H-benzimidazolderivater |
HRP960232A2 (en) * | 1995-07-03 | 1998-02-28 | Astra Ab | A process for the optical purification of compounds |
WO2000071539A1 (en) * | 1999-05-26 | 2000-11-30 | Pharm-Eco Laboratories Inc. | Methods of separating ftc isomers and derivatives thereof |
-
2001
- 2001-12-18 SE SE0104295A patent/SE0104295D0/sv unknown
-
2002
- 2002-12-17 CA CA002468688A patent/CA2468688A1/en not_active Abandoned
- 2002-12-17 US US10/498,944 patent/US20050049282A1/en not_active Abandoned
- 2002-12-17 JP JP2003552751A patent/JP2005517656A/ja active Pending
- 2002-12-17 WO PCT/SE2002/002356 patent/WO2003051867A1/en active Application Filing
- 2002-12-17 AU AU2002359151A patent/AU2002359151A1/en not_active Abandoned
- 2002-12-17 EP EP02793664A patent/EP1458709A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2003051867A1 (en) | 2003-06-26 |
US20050049282A1 (en) | 2005-03-03 |
EP1458709A1 (en) | 2004-09-22 |
CA2468688A1 (en) | 2003-06-26 |
AU2002359151A1 (en) | 2003-06-30 |
JP2005517656A (ja) | 2005-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0104295D0 (sv) | New process | |
EE200100248A (et) | Omeprasooli uus kristalne vorm | |
SE9900274D0 (sv) | New compound | |
WO1998054171A8 (en) | Novel form of s-omeprazole | |
SE9702483D0 (sv) | New compound | |
MXPA04000433A (es) | Procedimiento mejorado para preparar compuestos tipo bencimidazol. | |
DK1598340T3 (da) | 1-(4-piperidinyl)-1,3-dihydro-2H-benzoxazol -2-on derivater og beslægtede forbindelser som nociceptin analoger og ORL1 ligander til behandling af smerte | |
IS6897A (is) | Aðferðir til að framleiða útskipt 2-(2-pýridýlmetýl)súlfinýl-1H-bensimídasól | |
ZA989999B (en) | New process for the preparation of 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)1H-benzimidazole | |
WO2011042910A3 (en) | Optical resolution of substituted 2-(2- pyridinylmethylsulphinyl)-1h-benzimidazoles | |
SE0302382D0 (sv) | New salts II | |
SE0302381D0 (sv) | New salts I | |
DK1591122T3 (da) | Fremgangsmåde til indgivelse af bisphosphonater | |
DE60113161D1 (de) | Verfahren zur herstellung von 2-(4-pyridyl)amino-6-dialkylolxaphenyl-pyrido(2,3-d)pyrimidon-7-on-derivaten | |
DE60029493D1 (de) | Neues verfahren zur herstellung von 1-phenyl-2-(2-pyridyl)ethanamin | |
DK1490363T3 (da) | Fremgangsmåder til fremstilling af 2-7-chlor-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)1-isoindolinon | |
DK1615902T3 (da) | Fremgangsmåde til fremstilling af 4, 10beta-diacetoxy-2alfa-benzoyloxy-5beta,20-epoxy-1,13alfa-dihydroxy-9-oxo-19-norcyclopropa(g)tax-11-en | |
DK1285913T3 (da) | Fremgangsmåde til fremstilling af 3,5-dichlorpyridin | |
YU32301A (sh) | Novi kristalni oblik omeprazola | |
EA201190084A1 (ru) | Способ получения эзомепразола | |
ECSP003736A (es) | Procedimiento mejorado para la preparacion de derivados de bencimidazol adecuados como farmacos antiulcerosos, particularmente omeprazol o pantoprazol | |
UY26420A1 (es) | Procedimiento mejorado para la preparación de derivados bencimidazol adecuados como fármacos antiulcerosos, particularmente omeprazol o pantoprazol |